Innovations in Vaccine Research and Development

Available now, featuring Thermo Fisher R&D scientists

From the lab: Vaccine research and development

Reducing the spread of highly infectious and deadly diseases within the population, vaccine development is crucial in saving millions of lives each year. As a part of the scientific community working on novel vaccines, you are connected to a legacy that began with breakthroughs in the 18th century, and continues to break the boundaries of precision medicine.

Join our Thermo Fisher scientists as we give an overview of vaccine platforms and attributes, and discuss new vaccine research and development workflows in relation to SARS-CoV-2. Emphasis will be placed on the tools and workflows enabling rapid progress in vaccine development: innovative plasmid purification kits, RNA and DNA purification kits and reagents, and next gen protein expression systems. A Q&A session will follow as we explore various solutions that support research in vaccine development.

Complete the form below to watch our webinar and receive an adjoining presentation deck on:

An overview of vaccine research and development
Plasmid purification and other sample prep tools critical for vaccine research
Harnessing the power of Expi protein expression systems in vaccine development

(*Indicates a mandatory field)

First name*

Last name*

Telephone*

Email*

Institution*

City*

Country/Region*

Do you work with nucleic acid extraction?*

Yes—manual extraction—DNA isolation/purification

Yes—manual extraction—RNA isolation/purification

Yes—automated extraction methods

Yes—wastewater treatment or monitoring

Speakers

Alexander "Sasha" Vlassov
Senior Manager R&D at Thermo Fisher Scientific

Alexander “Sasha” Vlassov is a Sr. Manager Research & Development at Thermo Fisher Scientific. Dr. Vlassov has been leading a team of scientists at the Austin, Texas site for 13 years, focusing on development of next gen reagents, kits and instruments for COVID-19 testing, liquid biopsy, exosomes, and microbiome research applications. Prior to joining Thermo Fisher, he held various Research & Development positions at Invitrogen, Applied Biosystems, and Somagenics; Postdoctoral fellow at UC Boulder (Colorado), visiting scientist at IBMC (France), and research scientist at ICBFM (Russia). During his scientific career, Dr. Vlassov launched over 20 differentiated, commercially successful products and multi-million dollar product lines and co-authored over 70 publications and 10 patents.

Laura Chapman
Senior Staff Scientist, Thermo Fisher Scientific

Laura Chapman is a leading Senior Staff Scientist who develops the tools scientists use to isolate RNA and DNA from a wide range of sample types. She is responsible for co-developing the Invitrogen Cells-to-C_T kits, used to measure relative gene expression by real-time RT-qPCR without the need to purify RNA prior to amplification. She also supports the new the Ion AmpliSeq targeted RNA sequencing product, a next-generation sequencing (NGS) assay designed to accurately identify and measure the clonal expansion of T lymphocytes. Laura has extensive experience using plasmid purification kits for protein expression and transfection. She has a keen eye for process improvements and finding efficiencies during her tenure here at Thermo Fisher Scientific.

Ketil Pedersen
Manager & Staff Scientist, Thermo Fisher Scientific

Ketil Pedersen has been dedicating his career to research as a Staff Scientist for 14 years and is based out of Oslo, Norway. Ketil has extensive experience using Dynabeads for isolating cells, exosomes, and proteins from a wide range of sample types and managing his team of scientists. He is always happy to discuss science and technology-based challenges across his many fields of study including exosomes, immunoprecipitation, western blotting, cell isolation, and T cell activation. His work has been instrumental in the development of automated cell, exosomes, and protein isolation solutions that speed up processes or improve workflows. A recent notable publication is the automated pull-down of extracellular vesicles (EVs) on KingFisher systems using Dynabeads magnetic beads—standardizing EV capture and analysis.

Matt Mckenna
Sr. Field Applications Scientist, Thermo Fisher Scientific

Matt Mckenna has spent the last 18 years working in the Cambridge, Massachusetts area in both large pharma and small biotech settings. While mostly focused on transient protein expression, Matt also has extensive experience in developing stable cell lines expressing monoclonal antibodies. He has been with Thermo Fisher for 3 years and brings a wealth of hands-on experience using the Expi systems for protein expression. Previously, he worked for 7 years at Pfizer, where he helped develop an automated platform approach to transiently express hundreds of proteins per week using the Expi293 system. Recently, he co-authored the article Best Practices for Rapid High Titer Protein Expression.